Justine A Barletta

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. doi request reprint Immunohistochemical staining of thyroidectomy specimens for PTEN can aid in the identification of patients with Cowden syndrome
    Justine A Barletta
    Department of Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Am J Surg Pathol 35:1505-11. 2011
  2. doi request reprint A comprehensive analysis of PAX8 expression in human epithelial tumors
    Anna R Laury
    Department of Pathology, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    Am J Surg Pathol 35:816-26. 2011
  3. doi request reprint Immunohistochemistry using the BRAF V600E mutation-specific monoclonal antibody VE1 is not a useful surrogate for genotyping in colorectal adenocarcinoma
    Cheryl A Adackapara
    Department of Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Histopathology 63:187-93. 2013
  4. pmc Thyroid-specific knockout of the tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-κB activity
    Chi Iou Lin
    Department of Surgery, Brigham and Women s Hospital, Boston, MA 02115, USA
    Surgery 150:1295-302. 2011
  5. doi request reprint Identification of Succinate Dehydrogenase-deficient Bladder Paragangliomas
    Emily F Mason
    Department of Pathology, Brigham and Women s Hospital, Harvard Medical School Department of Pathology, Massachusetts General Hospital, Harvard Medical School Dana Farber Cancer Institute, Center for Sarcoma and Bone Oncology, Harvard Medical School, Boston, MA Department of Pathology, The Ottawa Hospital, Ottawa, ON, Canada
    Am J Surg Pathol 37:1612-8. 2013
  6. pmc Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus
    Scott J Rodig
    Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    J Clin Invest 122:4645-53. 2012
  7. doi request reprint Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications
    Justine A Barletta
    Department of Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Adv Anat Pathol 19:193-203. 2012
  8. pmc Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma
    Lynette M Sholl
    Department of Pathology, Brigham and Women s Hospital, Boston, MA 02115, USA
    Am J Surg Pathol 34:1193-8. 2010

Collaborators

Detail Information

Publications8

  1. doi request reprint Immunohistochemical staining of thyroidectomy specimens for PTEN can aid in the identification of patients with Cowden syndrome
    Justine A Barletta
    Department of Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Am J Surg Pathol 35:1505-11. 2011
    ..3%, respectively. In summary, loss of PTEN expression in adenomatous thyroid nodules, whether in all nodules or in a subset of nodules, appears to be both sensitive and specific for CS...
  2. doi request reprint A comprehensive analysis of PAX8 expression in human epithelial tumors
    Anna R Laury
    Department of Pathology, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    Am J Surg Pathol 35:816-26. 2011
    ..In a subset of cases, additional markers, including but not limited to thyroid transcription factor-1, RCC, and Wilms tumor-1, may be needed to distinguish between the 3 most common PAX8-positive tumors...
  3. doi request reprint Immunohistochemistry using the BRAF V600E mutation-specific monoclonal antibody VE1 is not a useful surrogate for genotyping in colorectal adenocarcinoma
    Cheryl A Adackapara
    Department of Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Histopathology 63:187-93. 2013
    ..A BRAF V600E-specific antibody has recently become commercially available. The aim of this study was to determine whether immunohistochemistry can predict BRAF mutations in CRC...
  4. pmc Thyroid-specific knockout of the tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-κB activity
    Chi Iou Lin
    Department of Surgery, Brigham and Women s Hospital, Boston, MA 02115, USA
    Surgery 150:1295-302. 2011
    ..Mitogen-inducible gene 6 (Mig-6) is a putative tumor suppressor gene and prognostic biomarker in papillary thyroid cancer. We hypothesized that Mig-6 knockout would activate pro-oncogenic signaling in mouse thyrocytes...
  5. doi request reprint Identification of Succinate Dehydrogenase-deficient Bladder Paragangliomas
    Emily F Mason
    Department of Pathology, Brigham and Women s Hospital, Harvard Medical School Department of Pathology, Massachusetts General Hospital, Harvard Medical School Dana Farber Cancer Institute, Center for Sarcoma and Bone Oncology, Harvard Medical School, Boston, MA Department of Pathology, The Ottawa Hospital, Ottawa, ON, Canada
    Am J Surg Pathol 37:1612-8. 2013
    ..A significant subset of bladder paragangliomas is SDH deficient. It is essential to identify SDH-deficient tumors, as the presence of an SDH mutation has prognostic implications and is important in guiding genetic counseling. ..
  6. pmc Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus
    Scott J Rodig
    Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    J Clin Invest 122:4645-53. 2012
    ..These results indicate that MCPyV is present in MCC tumors more frequently than previously reported and that mutations in TP53 tend to occur in MCC tumors that fail to express MCPyV large T antigen...
  7. doi request reprint Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications
    Justine A Barletta
    Department of Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Adv Anat Pathol 19:193-203. 2012
    ..This review will outline the genetics of SDH-deficient tumors, discuss possible mechanisms of tumorigenesis, and describe how these tumors can be identified by immunohistochemistry...
  8. pmc Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma
    Lynette M Sholl
    Department of Pathology, Brigham and Women s Hospital, Boston, MA 02115, USA
    Am J Surg Pathol 34:1193-8. 2010
    ..5; 95% CI 1.2-5.1), but not in women. Sox2 seems to be an independent predictor of poor outcome in stage I lung adenocarcinomas and may help stratify patients at increased risk for recurrence...